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Background: Early assessment of the final transmural extent of acute ST-elevation myocardial infarction (STEMI) treated with primary 
percutaneous coronary interventions is of major importance to predict left ventricular remodeling and prognosis. The study was aimed at evaluating 
the ability of basal and dobutamine stress 2D speckle tracking strain (S) imaging performed in the acute phase to predict final transmural extent of 
STEMI assessed by cardiac magnetic resonance (CMR) at 4 months.
Methods: 32 pts with a first STEMI (aged 60+/-7 years, 84% men, 72% anterior) reperfused within 12 hours underwent basal and low-dose (5-10 
/Kg/min) Dobutamine speckle tracking 2D S imaging at a median of 5 days after hospitalization. Longitudinal (L), radial and circumferential (C) S 
were evaluated on a 16-segment model of the left ventricle. CMR was performed 4 months after STEMI to assess segmental extent of MI. Transmural 
extent was defined as a >50% delayed enhancement (DE) of the infarcted segment. 2D S parameters and wall motion score at baseline and after 
dobutamine were evaluated as potential predictors of transmural extent of STEMI by univariable and multivariable analysis.
Results: At 4-month CMR DE was present in 187/512 (36%) segments analyzed, of whom 96/187 (51%) showed DE >50%. At univariate analysis 
basal LS (p<.0001) and CS (p<.0001), dobutamine LS (p=.001) and CS (p=.004), basal (p<.0001) and dobutamine wall motion score (p<.0001) 
were significant predictors of TME. By multivariable analysis only basal LS (Odds ratio 1.129, 95% confidence intervals 1.029-1.24, p=.011) and 
CS (Odds ratio 1.105, 95% confidence intervals 1.004-1.132, p=.037) remained significant predictors of the transmural extent of STEMI. ROC 
analysis showed an area under the curve of basal LS of .76 (95% confidence intervals .68-.83, p<.0001) for predicting 4-month transmural extent of 
infarction, with an optimal basal LS cut-off value of -9.10 (73% sensitivity and 70% specificity ).
Conclusions: In reperfused STEMI 2D S during the acute phase is able to predict transmural extent of infarction assessed by CMR at 4 months 
and may be of clinical value for early evaluation of remodeling and long-term prognosis.
